Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.78
-0.20 (-1.43%)
At close: Sep 12, 2025, 4:00 PM EDT
13.85
+0.07 (0.51%)
After-hours: Sep 12, 2025, 4:57 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $363.57 million as of September 12, 2025. Its market cap has increased by 285.11% in one year.
Market Cap
363.57M
Enterprise Value
260.94M
1-Year Change
285.11%
Ranking
Category
Stock Price
$13.78
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $363.57M, a decrease of -83.67%. That is a compound annual growth rate of -14.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 363.57M | 23.99% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | 13.22M | -90.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |